Diagnosis and treatment of ductal carcinoma in situ research.docVIP

 PAGE \* MERGEFORMAT 12 Diagnosis and treatment of ductal carcinoma in situ research Abstract With the further development of medical imaging, breast ductal carcinoma in situ of the number of cases increased significantly. Article on the breast ductal carcinoma in situ of the clinical manifestations and natural pathology, pathological features, diagnosis, treatment and prediction of postoperative local recurrence of the problem to make an analysis. Keywords: breast cancer Ductal carcinoma in situ (ductal carcinoma in situ, DCIS) refers to the ductal epithelial cells in dysplasia, but not beyond the basement membrane around the lesion, and belong to the same breast lobular carcinoma in situ breast carcinoma in situ. However, this disease really has developed into cancer or precancerous lesions is still in the proliferative phase is still discussed. 1932 Broders proposed the concept of carcinoma in situ are considered to belong to the scope of cancer, but only developed to penetrate the basement membrane to become invasive cancer, possible metastases. And many studies have shown that a considerable part of the carcinoma in situ always remain “in situ” rather than progressed to invasive carcinoma, so that in 2003 WHO classification published in Pathology will be in situ breast cancer as a “pre-cancerous lesions “category [1]. The 20th century, 80 years mammography screening is not widely used before, accounting for only 5% of all breast cancer (Table 1). 80 years, along with molybdenum target X-ray-based breast cancer secondary prevention work, an increasing number of DCIS were diagnosed. In the United States, DCIS breast cancer, the proportion of the total had risen to 10% ~ 15%, up to 30%. In film mammography detected breast cancer accounted for 30% [2], all of DCIS, 80% of a single detected by mammography [3]. Over the past palpation detected an average of tumor diameter 6cm, detected by mammography film is only an average diameter of 1c